Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Brain Neoplasms 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Completed × Pliability × Clear all
NCT04485767 2024-08-20

RESIST-ADT (Androgen Deprivation Therapy)

Dana-Farber Cancer Institute

Phase NA Completed
21 enrolled
Genitourinary

Prostatic Neoplasms

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed
10 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

NCT00766311 2012-01-09

XRCISL

St. Jude Children's Research Hospital

Phase NA Completed
20 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡